http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-942962-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc2f7134efa50484bb359fda73782848 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-66 |
| filingDate | 1961-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1963-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-942962-A |
| titleOfInvention | New triazine and process for its manufacture |
| abstract | The invention comprises 2-(21-phenylacetylhydrazino) - 4,6 - bis - diethylamino - 1,3,5 -triazine, acid addition salts thereof and its preparation by phenylacetylating 2-hydrazino -4,6- bis - diethylamino - 1,3,5 - triazine preferably with phenylacetyl chloride. Salts include those formed with methionine, tryptophan, lysine and arginine. Pharmaceutical compositions comprise the above compound or its salts in admixture or conjunction with a pharmaceutically suitable carrier and may be in the form of tablets, dragees, solutions, suspensions, or emulsions. The compounds show spinal blocking activity, making them suitable for treating neurological diseases, especially those with increased spasticity. Specification 825,072 is referred to. |
| priorityDate | 1960-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.